Hospital Universitario Marques De Valdecilla
Hospital Universitario Marques De Valdecilla is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
CHOP PLUS MOSUNETUZUMAB AS FIRST LINE IN PATIENTS WITH RICHTER´S SYNDROME: A PHASE II STUDY OF THE SPANISH GROUP OF CLL (GELLC-9-RICHTER)
Sponsor Not reported
- Start (EU)
- Latest update
- Estimated end
- Not reported
An open-label, prospective Phase III clinical study to compare polatuzumab vedotin plus rituximab, ifosfamide, carboplatin and etoposide (Pola-R-ICE) with rituximab, ifosfamide, carboplatin and etoposide (R-ICE) alone as salvage therapy in patients with primary refractory or relapsed diffuse large B-cell lymphoma (DLBCL)
Sponsor GWT-Tud GmbH
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Hospital Universitario Marques De Valdecilla?
The 2026-10-09 snapshot links Hospital Universitario Marques De Valdecilla to 2 distinct CTIS trials. Recorded services include Clinical monitoring, Electronic data capture, Investigator recruitment, Laboratory services, among 7 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Hospital Universitario Marques De Valdecilla?
The most frequently recorded therapeutic areas are Haematological Malignancies. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Hospital Universitario Marques De Valdecilla conducted?
The linked trials record locations in 3 countries, including Spain, Austria, Germany. These are trial locations, not confirmed office locations or countries where Hospital Universitario Marques De Valdecilla delivered services.
What can this page tell me about Hospital Universitario Marques De Valdecilla's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Hospital Universitario Marques De Valdecilla. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Hospital Universitario Marques De Valdecilla